Scotia

Article Abstract:

Scotia Holdings is a drug discovery company which is offering a convertible bond that represents an investment opportunity, although biotechnology companies have fallen out of fashion. The company has lost money since its stock flotation in 1993. The bonds offer a fixed interest paid twice a year at 8.5% yearly. The company plans to seek regulatory approval for its Foscan anti-cancer treatment in Europe and the US in 1999. The company has also produced a food additive called Olibra which functions as an appetite suppressant.

User Contributions:

1

eric

Nov 9, 2009 @ 11:11 am

Does anyone have any idea what has happened to the convertible stock

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Scotia

Article Abstract:

Scotia has a promising product in Foscan which could bring marketing royalties, though there is no guarantee that it will achieve regulatory approval.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Theratase

Article Abstract:

Theratase supplies enzymes and biochemicals and has undergone a recovery, though there are costs linked to preference share repayments.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: